Clinical Trial Update: Pleurodesis Using Hypertonic Glucose [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on pleurodesis using hypertonic glucose for air leaks from the lung.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Air Leak From Lung

Drugs mentioned

• Hypertonic glucose (hypertonic glucose sclerosant)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Air Leak From Lung | Phase 2 | Status: UNKNOWN